WHO Target Product Profile for Plague Vaccines

Overview

Selected disease areas are identified as WHO priorities for product development. The recrudescence of plague outbreaks, the availability of new vaccine technologies, and biodefense concerns have triggered renewed interest in the development of new-generation plague vaccines. 

This document aims to set out preferred and minimal characteristics for next-generation plague vaccines from a public health perspective. The target audience includes vaccine scientists, product developers, manufacturers, funding agencies and policymakers.